Complete Genomics is a life sciences company that has developed and commercialized an innovative DNA sequencing platform. The Complete Genomics Analysis Platform (CGA™ Platform) combines Complete Genomics’ proprietary human genome sequencing technology with our advanced informatics and data management software. We offer this solution as an innovative, end-to-end, outsourced service, CGA™ Service, and provide customers with data that is immediately ready to be used for genome-based research.
Complete Genomics, Inc. is backed by a group of top-tier investors including Essex Woodlands, Orbimed, OVP, Enterprise Partners, Prospect Ventures and Sands Capital Management.
For more information on Complete Genomics, Inc., please visit their web site at www.completegenomics.com